OPDIVO QVANTIG 2000 U/mL
nivolumab and hyaluronidase-nvhy · INJECTION, SOLUTION · E.R. Squibb & Sons, L.L.C.
OPDIVO QVANTIG is a injection, solution containing nivolumab and hyaluronidase-nvhy at 2000 U/mL, taken subcutaneous. Manufactured by E.R. Squibb & Sons, L.L.C..
Key Facts
- Brand Name
- OPDIVO QVANTIG
- Generic Name
- nivolumab and hyaluronidase-nvhy
- NDC Code (Product)
0003-3120- Manufacturer
- E.R. Squibb & Sons, L.L.C.
- Strength
- 2000 U/mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA761381
- Drug Class
- Endoglycosidase [EPC]; Programmed Death Receptor-1 Blocking Antibody [EPC]
- Marketing Start
- 12/27/2024
Recall History
No Recall HistoryFrequently Asked Questions
What is OPDIVO QVANTIG used for?
OPDIVO QVANTIG contains nivolumab and hyaluronidase-nvhy. It is a injection, solution taken subcutaneous. Consult your doctor for specific uses.
Is OPDIVO QVANTIG a controlled substance?
OPDIVO QVANTIG is not classified as a controlled substance by the DEA.
What is the generic name for OPDIVO QVANTIG?
The generic name for OPDIVO QVANTIG is nivolumab and hyaluronidase-nvhy. There are no other listed brand versions of nivolumab and hyaluronidase-nvhy.
What is the NDC code for OPDIVO QVANTIG 2000 U/mL?
The NDC (National Drug Code) for OPDIVO QVANTIG 2000 U/mL is 0003-3120, listed by E.R. Squibb & Sons, L.L.C..
Other OPDIVO QVANTIG Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)